Possibility of steroid therapy without pacemaker implantation in patients with sarcoidosis presenting atrioventricular block
- PMID: 35568741
- DOI: 10.1007/s00380-022-02092-1
Possibility of steroid therapy without pacemaker implantation in patients with sarcoidosis presenting atrioventricular block
Abstract
Atrioventricular Block (AVB) is one of the common manifestations in cardiac sarcoidosis (CS). Although pacemaker implantation is generally recommended in patients with CS complicated by symptomatic AVB, some case reports have shown that they can be managed by steroid therapy without pacemaker implantation. The aim of this study was to evaluate the feasibility and effectiveness of steroid therapy without pacemaker implantation in patients with CS complicated by symptomatic AVB. We performed medical record review of consecutive ten CS patients who admitted Nippon Medical School Hospital for symptomatic second or third degree AVB between April 2015 and March 2021. Of the studied population, steroid therapy before pacemaker implantation was feasible in three patients with second degree AVB. Two of them showed subsequent recovery of atrioventricular conduction to 1:1, and they were managed by steroid therapy without pacemaker. The remaining one patient showed no improvement of atrioventricular conduction and required pacemaker implantation. Seven patients with third degree AVB required device implantation (pacemaker; n = 7, cardiac resynchronization therapy defibrillator; n = 1) before steroid therapy mainly because of hemodynamic instability. Steroid therapy without pacemaker implantation might be feasible, and possibly be effective in patients with CS presenting second degree AVB. However, the feasibility is limited in patients with third degree AVB.
Keywords: Atrioventricular block; Cardiac sarcoidosis; Recovery; Steroid.
© 2022. Springer Japan KK, part of Springer Nature.
Comment in
-
Atrioventricular block in the setting of cardiac sarcoidosis: further implications.Heart Vessels. 2023 May;38(5):753-754. doi: 10.1007/s00380-022-02136-6. Epub 2022 Jul 5. Heart Vessels. 2023. PMID: 35789419 No abstract available.
-
Therapeutic strategy for those with atrioventricular block and cardiac sarcoidosis.Heart Vessels. 2023 Apr;38(4):614. doi: 10.1007/s00380-022-02135-7. Epub 2022 Jul 8. Heart Vessels. 2023. PMID: 35802182 No abstract available.
Similar articles
-
Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults.Circ Arrhythm Electrophysiol. 2011 Jun;4(3):303-9. doi: 10.1161/CIRCEP.110.959254. Epub 2011 Mar 22. Circ Arrhythm Electrophysiol. 2011. PMID: 21427276
-
Clinical characteristics associated with pacing-induced cardiac dysfunction: a high incidence of undiagnosed cardiac sarcoidosis before permanent pacemaker implantation.Heart Vessels. 2018 Dec;33(12):1505-1514. doi: 10.1007/s00380-018-1206-5. Epub 2018 Jun 21. Heart Vessels. 2018. PMID: 29931541
-
Rates and predictors for sustained ventricular tachycardia in patients with cardiac sarcoidosis and AV block as first cardiac presentation: Implications for device implantation.Heart Rhythm. 2025 Jun;22(6):1598-1605. doi: 10.1016/j.hrthm.2024.09.020. Epub 2024 Sep 14. Heart Rhythm. 2025. PMID: 39284399
-
Comparing outcomes of an 'early' versus 'late' diagnosis of cardiac sarcoidosis following a baseline presentation of high-grade atrioventricular block.Curr Probl Cardiol. 2024 Jul;49(7):102577. doi: 10.1016/j.cpcardiol.2024.102577. Epub 2024 Apr 21. Curr Probl Cardiol. 2024. PMID: 38653441 Review.
-
A systematic review of the clinical characteristics and course of atrioventricular blocks in hyperthyroidism.Ann Med. 2024 Dec;56(1):2365405. doi: 10.1080/07853890.2024.2365405. Epub 2024 Jun 21. Ann Med. 2024. PMID: 38902995 Free PMC article.
Cited by
-
Recovery of Transient High-Grade Atrioventricular Block Managed With Corticosteroid Therapy Without Device Implantation in Newly Diagnosed Cardiac Sarcoidosis: A Case Report.Cureus. 2023 Jul 6;15(7):e41481. doi: 10.7759/cureus.41481. eCollection 2023 Jul. Cureus. 2023. PMID: 37554599 Free PMC article.
-
Cardiac Sarcoidosis: Clinical Insights, Diagnosis, and Management Strategies.Rev Cardiovasc Med. 2025 Feb 21;26(2):26605. doi: 10.31083/RCM26605. eCollection 2025 Feb. Rev Cardiovasc Med. 2025. PMID: 40026523 Free PMC article. Review.
-
Cardiac Masses and Pseudomasses: An Overview about Diagnostic Imaging and Clinical Background.Medicina (Kaunas). 2023 Dec 29;60(1):70. doi: 10.3390/medicina60010070. Medicina (Kaunas). 2023. PMID: 38256331 Free PMC article. Review.
-
Fragmented QRS on 12-lead electrocardiogram predicts long-term prognosis in patients with cardiac sarcoidosis.Heart Vessels. 2023 Jun;38(6):803-816. doi: 10.1007/s00380-022-02229-2. Epub 2023 Jan 13. Heart Vessels. 2023. PMID: 36635468
-
Management of the arrhythmic manifestations of cardiac sarcoidosis.Front Cardiovasc Med. 2023 May 25;10:1104947. doi: 10.3389/fcvm.2023.1104947. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 37304969 Free PMC article. Review.
References
-
- Birnie DH, Sauer WH, Bogun F, Cooper JM, Culver DA, Duvernoy CS, Judson MA, Kron J, Mehta D, Cosedis Nielsen J, Patel AR, Ohe T, Raatikainen P, Soejima K (2014) HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 11:1305–1323 - DOI
-
- Terasaki F, Azuma A, Anzai T, Ishizaka N, Ishida Y, Isobe M, Inomata T, Ishibashi-Ueda H, Eishi Y, Kitakaze M, Kusano K, Sakata Y, Shijubo N, Tsuchida A, Tsutsui H, Nakajima T, Nakatani S, Horii T, Yazaki Y, Yamaguchi E, Yamaguchi T, Ide T, Okamura H, Kato Y, Goya M, Sakakibara M, Soejima K, Nagai T, Nakamura H, Noda T, Hasegawa T, Morita H, Ohe T, Kihara Y, Saito Y, Sugiyama Y, Morimoto SI, Yamashina A (2019) JCS 2016 Guideline on diagnosis and treatment of cardiac sarcoidosis - digest version. Circ J 83:2329–2388 - DOI
-
- Nogami A, Kurita T, Abe H, Ando K, Ishikawa T, Imai K, Usui A, Okishige K, Kusano K, Kumagai K, Goya M, Kobayashi Y, Shimizu A, Shimizu W, Shoda M, Sumitomo N, Seo Y, Takahashi A, Tada H, Naito S, Nakazato Y, Nishimura T, Nitta T, Niwano S, Hagiwara N, Murakawa Y, Yamane T, Aiba T, Inoue K, Iwasaki Y, Inden Y, Uno K, Ogano M, Kimura M, Sakamoto SI, Sasaki S, Satomi K, Shiga T, Suzuki T, Sekiguchi Y, Soejima K, Takagi M, Chinushi M, Nishi N, Noda T, Hachiya H, Mitsuno M, Mitsuhashi T, Miyauchi Y, Miyazaki A, Morimoto T, Yamasaki H, Aizawa Y, Ohe T, Kimura T, Tanemoto K, Tsutsui H, Mitamura H (2021) JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias. J Arrhythm 37:709–870 - DOI
-
- Okamoto H, Mizuno K, Ohtoshi E (1999) Cutaneous sarcoidosis with cardiac involvement. Eur J Dermatol 9:466–469 - PubMed
-
- Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H (2003) Efficacy of corticosteroids in sarcoidosis presenting with atrioventricular block. Sarcoidosis Vasc Diffuse Lung Dis 20:133–137 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous